Newsroom

Press Releases

The latest news from Guardant Health AMEA, including partnership announcements and product news.

2024

August 30

Guardant Health Japan receives regulatory approval of Guardant360® CDx liquid biopsy as companion diagnostic for amivantamab-vmjw to identify patients with inoperable or recurrent NSCLC harbouring EGFR exon 20 insertion mutations

July 17

Guardant Health Japan submits application for regulatory approval of Guardant360® CDx in Japan as companion diagnostic for Janssen lung cancer therapy

May 16

First batch of blood samples has been tested for prospective clinical trials using the Guardant360® liquid biopsy in the Adicon laboratory in China

April 2

Adicon offers GuardantOMNI® liquid biopsy test for clinical trials in China with equivalent performance to Guardant Health’s US-based laboratory test

February 5

Adicon begins clinical trials sample testing upon completion of Analytical Validation Studies of the Guardant360® liquid biopsy in China

January 8

Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa

2023

September 5

Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations

July 5

Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan

May 30

Guardant Health Receives Regulatory Approval from Singapore’s Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers

2022

July 6

Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China

June 13

Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture

March 14

Guardant Health Receives Regulatory Approval for Guardant360® CDx in Japan

2020

December 15

Guardant Health AMEA Wins Frost & Sullivan’s Market Leadership Award for Liquid Biopsy in Precision Oncology in Asia, Middle East and Africa

August 7

First liquid biopsy to receive FDA Approval for comprehensive tumor mutation profiling across all solid cancers, Guardant Health’s Guardant360® CDx, advancing precision oncology in Asia, Middle East and Africa

May 30

Guardant360® test results may provide prognostic information beyond the detection of actionable biomarkers for ALK-rearranged NSCLC patients

2018

November 13

Precision Oncology Company Guardant Health AMEA announces launch of its Asia, Middle East and Africa region headquarters in Singapore

Featured Stories & Perspectives

TransformAsians | Sep 6, 2023

Conquering Cancer with Simranjit Singh

BioSpectrum Asia | May 4, 2023

Precision oncology is redefining cancer care at all stages of the disease

Fierce Biotech | Jul 6, 2022

Guardant Health takes its cancer tests to China through clinical partnership

MEDIA INQUIRIES

Get in Touch with Our AMEA Communications Team

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Advertisement

Others